Tokyo, Japan

Kazuyuki Hamada

USPTO Granted Patents = 18 

 

Average Co-Inventor Count = 2.9

ph-index = 6

Forward Citations = 171(Granted Patents)


Location History:

  • Funabashi, JP (1993)
  • Tenri, JP (1994)
  • Yokosuka, JP (2006)
  • Nara, JP (2004 - 2009)
  • Hachioji, JP (2011)
  • Ube, JP (2001 - 2013)
  • Osaka, JP (2005 - 2013)
  • Tokyo, JP (1994 - 2019)
  • Oume, JP (2024)

Company Filing History:


Years Active: 1993-2024

Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents

Title: Kazuyuki Hamada: Innovator in Monoclonal Antibody Technology

Introduction

Kazuyuki Hamada is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 17 patents to his name, Hamada's work has advanced the understanding and application of sugar chains in biological systems.

Latest Patents

Hamada's latest patents include a monoclonal antibody that specifically binds to a sugar chain where the terminal sialic acid residue is bonded to galactose by an alpha 2,3 bond. This innovative antibody is designed to remain attached to the sugar chain after binding, enhancing its utility in various applications. Additionally, he has developed a measurement method for this sugar chain, which involves an automatic analyzing apparatus. This apparatus features a chip rack that stores a pipette chip, a conveyance unit, and a detection unit, allowing for precise optical detection of specimens.

Career Highlights

Throughout his career, Kazuyuki Hamada has worked with notable companies such as Sharp Corporation and System Instruments Co., Ltd. His experience in these organizations has contributed to his expertise in the field of biotechnology and patent development.

Collaborations

Hamada has collaborated with esteemed colleagues, including Takeshi Akiba and Shoji Tanaka. These partnerships have fostered innovation and have been instrumental in the advancement of his research.

Conclusion

Kazuyuki Hamada's contributions to the field of monoclonal antibodies and sugar chain analysis highlight his role as a leading inventor in biotechnology. His patents and collaborations continue to influence the industry and pave the way for future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…